Mental retardation secondary prevention: Difference between revisions
Jump to navigation
Jump to search
Homa Najafi (talk | contribs) Created page with "__NOTOC__ {{Mental retardation}} {{CMG}} {{AE}}{{Chelsea}} ==Overview== There are no established measures for the secondary prevention of [disease name]. OR Effective measur..." |
|||
Line 2: | Line 2: | ||
{{Mental retardation}} | {{Mental retardation}} | ||
{{CMG}} {{AE}}{{Chelsea}} | {{CMG}} {{AE}}{{Chelsea}} | ||
==Secondary Prevention== | ==Secondary Prevention== | ||
There are no established measures for the secondary prevention of [disease name]. | There are no established measures for the secondary prevention of [disease name]. |
Revision as of 02:39, 20 July 2021
Mental retardation Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Mental retardation secondary prevention On the Web |
American Roentgen Ray Society Images of Mental retardation secondary prevention |
Risk calculators and risk factors for Mental retardation secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Chelsea Mae Nobleza, M.D.[2]
Secondary Prevention
There are no established measures for the secondary prevention of [disease name].
OR
Effective measures for the secondary prevention of [disease name] include:
- [Strategy 1]
- [Strategy 2]
- [Strategy 3]